166 related articles for article (PubMed ID: 35205698)
1. Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.
Stie M; Delmar C; Nørgaard B; Jensen LH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205698
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.
Stie M; Delmar C; Nørgaard B; Jensen LH
BMJ Open; 2022 Apr; 12(4):e059960. PubMed ID: 35470199
[TBL] [Abstract][Full Text] [Related]
3. Open dialogue about complementary and alternative medicine (CAM) integrated in conventional oncology care, characteristics and impact. A systematic review.
Stie M; Jensen LH; Delmar C; Nørgaard B
Patient Educ Couns; 2020 Nov; 103(11):2224-2234. PubMed ID: 32563705
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for metastatic renal cell carcinoma.
Unverzagt S; Moldenhauer I; Nothacker M; Roßmeißl D; Hadjinicolaou AV; Peinemann F; Greco F; Seliger B
Cochrane Database Syst Rev; 2017 May; 5(5):CD011673. PubMed ID: 28504837
[TBL] [Abstract][Full Text] [Related]
5. Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: a randomised controlled trial.
Chong WQ; Mogro MJ; Arsad A; Tai BC; Lee SC
Support Care Cancer; 2021 Jul; 29(7):3689-3696. PubMed ID: 33188612
[TBL] [Abstract][Full Text] [Related]
6. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer.
Jefford M; Gough K; Drosdowsky A; Russell L; Aranda S; Butow P; Phipps-Nelson J; Young J; Krishnasamy M; Ugalde A; King D; Strickland A; Franco M; Blum R; Johnson C; Ganju V; Shapiro J; Chong G; Charlton J; Haydon A; Schofield P
Oncologist; 2016 Aug; 21(8):1014-23. PubMed ID: 27306909
[TBL] [Abstract][Full Text] [Related]
8. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer.
Lengacher CA; Bennett MP; Kip KE; Gonzalez L; Jacobsen P; Cox CE
Oncol Nurs Forum; 2006 Jan; 33(1):97-104. PubMed ID: 16470237
[TBL] [Abstract][Full Text] [Related]
9. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in terminally ill cancer patients: what is the role of using complementary and alternative medicines?
Dehghan M; Hoseini FS; Mohammadi Akbarabadi F; Fooladi Z; Zakeri MA
Support Care Cancer; 2022 Nov; 30(11):9421-9432. PubMed ID: 35915340
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.
Mobed K; Liu R; Stewart S; Wrensch M; McCoy L; Rice T; Prados M; Chang S
J Support Oncol; 2009; 7(6):W23-W31. PubMed ID: 26692824
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy.
Niska JR; Thorpe CS; Halyard MY; Tan AD; Atherton PJ; Dueck AC; Patel SH; Sloan JA
J Patient Rep Outcomes; 2020 Jul; 4(1):60. PubMed ID: 32677021
[TBL] [Abstract][Full Text] [Related]
13. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of integrating individualized and generic complementary medicine treatments with standard care versus standard care alone for reducing preoperative anxiety.
Attias S; Keinan Boker L; Arnon Z; Ben-Arye E; Bar'am A; Sroka G; Matter I; Somri M; Schiff E
J Clin Anesth; 2016 Mar; 29():54-64. PubMed ID: 26897450
[TBL] [Abstract][Full Text] [Related]
15. Cancer Impact, Complementary/Alternative Medicine Beliefs, and Quality of Life in Cancer Patients.
Kuo YH; Tsay SL; Chang CC; Liao YC; Tung HH
J Altern Complement Med; 2018 Mar; 24(3):276-281. PubMed ID: 28876080
[TBL] [Abstract][Full Text] [Related]
16. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.
Klafke N; Mahler C; von Hagens C; Rochon J; Schneeweiss A; Müller A; Salize HJ; Joos S
Trials; 2015 Feb; 16():51. PubMed ID: 25887713
[TBL] [Abstract][Full Text] [Related]
17. Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study.
Wode K; Henriksson R; Sharp L; Stoltenberg A; Hök Nordberg J
BMC Complement Altern Med; 2019 Mar; 19(1):62. PubMed ID: 30866916
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Predictors for Nonuse of Complementary Medicine among Breast and Gynecological Cancer Patients.
Paepke D; Wiedeck C; Hapfelmeier A; Karmazin K; Kiechle M; Brambs C
Breast Care (Basel); 2020 Aug; 15(4):380-385. PubMed ID: 32982648
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and complementary and alternative medicine use among women with breast cancer.
Albabtain H; Alwhaibi M; Alburaikan K; Asiri Y
Saudi Pharm J; 2018 Mar; 26(3):416-421. PubMed ID: 29556133
[TBL] [Abstract][Full Text] [Related]
20. Complementary and Alternative Medicine Use and Symptom Burden in Women Undergoing Chemotherapy for Breast Cancer in Malaysia.
Chui PL; Abdullah KL; Wong LP; Taib NA
Cancer Nurs; 2018; 41(3):189-199. PubMed ID: 28723722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
